EP1222199A4 - N-formylpeptid-rezeptorkomplex mit einer substanz, die einen g-protein-kinase-signalübertragungsweg modifiziert - Google Patents
N-formylpeptid-rezeptorkomplex mit einer substanz, die einen g-protein-kinase-signalübertragungsweg modifiziertInfo
- Publication number
- EP1222199A4 EP1222199A4 EP00970817A EP00970817A EP1222199A4 EP 1222199 A4 EP1222199 A4 EP 1222199A4 EP 00970817 A EP00970817 A EP 00970817A EP 00970817 A EP00970817 A EP 00970817A EP 1222199 A4 EP1222199 A4 EP 1222199A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- protein kinase
- receptor complex
- modification agent
- signal pathway
- peptide receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15967799P | 1999-10-15 | 1999-10-15 | |
US159677P | 1999-10-15 | ||
PCT/US2000/028183 WO2001029069A1 (en) | 1999-10-15 | 2000-10-12 | N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1222199A1 EP1222199A1 (de) | 2002-07-17 |
EP1222199A4 true EP1222199A4 (de) | 2003-03-12 |
Family
ID=22573520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00970817A Withdrawn EP1222199A4 (de) | 1999-10-15 | 2000-10-12 | N-formylpeptid-rezeptorkomplex mit einer substanz, die einen g-protein-kinase-signalübertragungsweg modifiziert |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1222199A4 (de) |
JP (1) | JP2004507441A (de) |
KR (1) | KR20020057972A (de) |
CN (1) | CN100497374C (de) |
AU (1) | AU8014200A (de) |
BR (1) | BR0014742A (de) |
CA (1) | CA2387559A1 (de) |
CZ (1) | CZ20021342A3 (de) |
EA (1) | EA200200451A1 (de) |
HU (1) | HUP0203688A2 (de) |
IL (1) | IL149125A0 (de) |
MX (1) | MXPA02003782A (de) |
NO (1) | NO20021732L (de) |
PL (1) | PL356096A1 (de) |
WO (1) | WO2001029069A1 (de) |
ZA (1) | ZA200202937B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6844315B2 (en) | 1998-05-20 | 2005-01-18 | Erasmus Universiteit Rotterdam | Immunoregulator |
EP1138692A1 (de) | 2000-03-29 | 2001-10-04 | Erasmus Universiteit Rotterdam | Fragmente des menschlichen Choriongonadotropins als Immunoregulatoren |
US20030220258A1 (en) | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
US8680059B2 (en) | 1998-05-20 | 2014-03-25 | Biotempt B.V. | Oligopeptide acetate and formulations thereof |
USRE43279E1 (en) | 2000-03-29 | 2012-03-27 | Biotemp B.V. | Compositions capable of reducing elevated blood urea concentration |
US7358330B2 (en) | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
EP1300418A1 (de) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Genregulation durch Oligopeptide |
US7786084B2 (en) | 2001-12-21 | 2010-08-31 | Biotempt B.V. | Treatment of burns |
US20070116687A1 (en) * | 2003-05-13 | 2007-05-24 | Medvet Science Pty, Ltd. | Method of modulating cellular transmigration and agents for use therein |
WO2007004869A2 (en) | 2005-07-05 | 2007-01-11 | Biotempt B.V. | Treatment of tumors |
EP1864692A1 (de) | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Verwendung von peptiden zum Schutz von Strahlenschäden |
EP2483683A1 (de) * | 2009-09-28 | 2012-08-08 | TheraMab GmbH | Verfahren zur präklinischen prüfung von immunmodulatorischen stoffen |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999025372A1 (en) * | 1997-11-13 | 1999-05-27 | Histatek, Llc | Small peptides and methods for treatment of asthma and inflammation |
-
2000
- 2000-10-12 WO PCT/US2000/028183 patent/WO2001029069A1/en active Application Filing
- 2000-10-12 CZ CZ20021342A patent/CZ20021342A3/cs unknown
- 2000-10-12 HU HU0203688A patent/HUP0203688A2/hu unknown
- 2000-10-12 JP JP2001531867A patent/JP2004507441A/ja active Pending
- 2000-10-12 MX MXPA02003782A patent/MXPA02003782A/es not_active Application Discontinuation
- 2000-10-12 PL PL00356096A patent/PL356096A1/xx not_active Application Discontinuation
- 2000-10-12 IL IL14912500A patent/IL149125A0/xx unknown
- 2000-10-12 KR KR1020027004714A patent/KR20020057972A/ko not_active Application Discontinuation
- 2000-10-12 CA CA002387559A patent/CA2387559A1/en not_active Abandoned
- 2000-10-12 AU AU80142/00A patent/AU8014200A/en not_active Abandoned
- 2000-10-12 EA EA200200451A patent/EA200200451A1/ru unknown
- 2000-10-12 EP EP00970817A patent/EP1222199A4/de not_active Withdrawn
- 2000-10-12 BR BR0014742-7A patent/BR0014742A/pt not_active IP Right Cessation
- 2000-10-12 CN CNB008156867A patent/CN100497374C/zh not_active Expired - Fee Related
-
2002
- 2002-04-12 NO NO20021732A patent/NO20021732L/no not_active Application Discontinuation
- 2002-04-15 ZA ZA200202937A patent/ZA200202937B/xx unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999025372A1 (en) * | 1997-11-13 | 1999-05-27 | Histatek, Llc | Small peptides and methods for treatment of asthma and inflammation |
Non-Patent Citations (6)
Title |
---|
ALI H ET AL: "Chemoattractant receptor cross-desensitization.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. UNITED STATES 5 MAR 1999, vol. 274, no. 10, 5 March 1999 (1999-03-05), pages 6027 - 6030, XP002226343, ISSN: 0021-9258 * |
DENG X ET AL: "A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R.", BLOOD. UNITED STATES 15 AUG 1999, vol. 94, no. 4, 15 August 1999 (1999-08-15), pages 1165 - 1173, XP002226344, ISSN: 0006-4971 * |
GRONERT K ET AL: "Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.", THE JOURNAL OF EXPERIMENTAL MEDICINE. UNITED STATES 20 APR 1998, vol. 187, no. 8, 20 April 1998 (1998-04-20), pages 1285 - 1294, XP002226394, ISSN: 0022-1007 * |
KANAHO Y ET AL: "COMPARISON OF STIMULATION BY CHEMOTACTIC FORMYL PEPTIDE ANALOGS BETWEEN GTPASE ACTIVITY IN NEUTROPHIL PLASMA MEMBRANES AND GRANULE ENZYME RELEASE FROM INTACT NEUTROPHILS", JOURNAL OF LEUKOCYTE BIOLOGY, vol. 47, no. 5, 1990, pages 420 - 428, XP008012138, ISSN: 0741-5400 * |
See also references of WO0129069A1 * |
TORRES M ET AL: "Activation of the mitogen-activated protein kinase pathway by fMet-leu-Phe in the absence of Lyn and tyrosine phosphorylation of SHC in transfected cells.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. UNITED STATES 31 MAY 1996, vol. 271, no. 22, 31 May 1996 (1996-05-31), pages 13244 - 13249, XP002226470, ISSN: 0021-9258 * |
Also Published As
Publication number | Publication date |
---|---|
EA200200451A1 (ru) | 2002-10-31 |
WO2001029069A1 (en) | 2001-04-26 |
AU8014200A (en) | 2001-04-30 |
IL149125A0 (en) | 2002-11-10 |
HUP0203688A2 (hu) | 2003-02-28 |
CN100497374C (zh) | 2009-06-10 |
CA2387559A1 (en) | 2001-04-26 |
KR20020057972A (ko) | 2002-07-12 |
CZ20021342A3 (cs) | 2003-01-15 |
CN1633447A (zh) | 2005-06-29 |
PL356096A1 (en) | 2004-06-14 |
JP2004507441A (ja) | 2004-03-11 |
NO20021732L (no) | 2002-06-12 |
BR0014742A (pt) | 2002-08-27 |
NO20021732D0 (no) | 2002-04-12 |
EP1222199A1 (de) | 2002-07-17 |
MXPA02003782A (es) | 2002-12-13 |
ZA200202937B (en) | 2003-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1029349A1 (en) | Kappa receptor opioid peptides | |
IL143226A0 (en) | Pyrrolidine derivatives-ccr-3 receptor antagonists | |
EP1104440A4 (de) | Ein g-protein-gekoppelten 7 transmembranrezeptor | |
AU1956701A (en) | G-protein coupled receptors | |
IL149125A0 (en) | N-formyl peptide receptor complex with a g-protein kinase signal pathway modification agent | |
EP1229910A4 (de) | Integrinrezeptorantagonisten | |
SG80041A1 (en) | Muscarinic receptor antagonists | |
EP1194151A4 (de) | Antagonisten der integrin rezeptoren | |
EP1157038A4 (de) | KLONIERUNG EINES P2Y-äHNLICHEN 7TM-REZEPTORS (AXOR17) | |
HK1042099A1 (zh) | 人g-蛋白偶聯受體 | |
IL196053A0 (en) | Novel human g-protein coupled receptor | |
IL148515A0 (en) | Human g-protein coupled receptor | |
EP1233981A4 (de) | An ein g-protein gekoppelter rezeptor | |
IL146146A0 (en) | Integrin receptor antagonists | |
AU4511901A (en) | Nonpeptide kappa opioid receptor antagonists | |
AU5344799A (en) | Kappa (op2) opioid receptor antagonists | |
AU6051200A (en) | Il-8 receptor antagonists | |
EP1171467A4 (de) | Axor-27, ein an ein g-protein gekoppelter rezeptor | |
EP1071766A4 (de) | MENSCHLICHER, AN EIN G-PROTEIN GEKOPPELTER REZEPTOR MIT DER BEZEICHNUNG GPR6sb. | |
EP1129101A4 (de) | An den 7tm-rezeptor gekoppeltes g-protein | |
AU5572500A (en) | Vegf receptor antagonists | |
AU5748300A (en) | Il-8 receptor antagonists | |
PL357650A1 (en) | Non peptide tachykinin receptor antagonists | |
EP1226435A4 (de) | Axor35, ein an ein g-protein gekoppelter rezeptor | |
AU8183601A (en) | A g-protein coupled receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020415 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 38/05 B Ipc: 7C 07K 14/72 B Ipc: 7C 07K 14/00 A Ipc: 7G 01N 33/53 B Ipc: 7A 61K 38/07 B Ipc: 7G 01N 33/50 B Ipc: 7A 61P 37/06 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030123 |
|
17Q | First examination report despatched |
Effective date: 20031212 |
|
18D | Application deemed to be withdrawn |
Effective date: 20040623 |
|
18RA | Request filed for re-establishment of rights before grant |
Effective date: 20050329 |
|
R18Z | Request filed for re-establishment of rights before grant (corrected) |
Effective date: 20050329 |
|
D18D | Application deemed to be withdrawn (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MOWYCAL LENDING, LLC |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
R18D | Application deemed to be withdrawn (corrected) |
Effective date: 20120503 |